City
Epaper

COVID-19 Vaccine: Bombay High Court refuses to hear plea on differential pricing of vaccines

By Lokmat English Desk | Updated: April 29, 2021 16:50 IST

The third phase of corona vaccination across the country is starting from May 1. Emphasis is being placed on ...

Open in App

The third phase of corona vaccination across the country is starting from May 1. Emphasis is being placed on corona vaccination against the backdrop of increasing covid cases. The third phase of corona vaccination is very important and everyone above the age of 18 will be vaccinated. Against this backdrop, a petition was filed in the Bombay High Court seeking a direction to the Serum Institute of India and the Bharat Biotech to sell their COVID-19 vaccines at a uniform rate of ₹150 (plus GST) per dose. However, the court has refused to hear the petition.

The Serum Institute recently announced the price of the corona vaccine. After that the price of its vaccine was reduced from ₹400 to ₹300 per dose to the State governments. The public interest litigation (PIL), filed last week by Mumbai-based advocate Fayzan Khan in the Bombay High Court seeking an order to provide corona vaccine at the same rate of Rs 150 per dose across the country. However, High Court Chief Justice Dipankar Dutta has refused to hear the petition and advised the petitioners to approach the Supreme Court.

The Supreme Court has already made it clear that issues that have pan-India effect will be dealt with by them and pricing is a phenomenon applicable all over India. The Supreme Court has taken notice even before you filed the petition. You can appeal to them, explained Justice Dipankar Dutta.We have an idea of ​​the situation and are constantly telling the Central and State Governments to ensure that people get better treatment, ”the High Court said in a statement.

Meanwhile, the country is focusing on vaccination and from May 1, everyone above the age of 18 will be vaccinated. However, vaccination will not start in Maharashtra, state health minister Rajesh Tope said after a cabinet meeting on Wednesday. Tope added that the decision was made because of the low availability of vaccine doses.

Tags: Bombay High CourtSerum institue of indiaCoronavirus VaccineCovid-19CoronavirusCovishieldCovaxin
Open in App

Related Stories

ThaneThane Municipal Corporation Launches Metropolitan Surveillance Unit To Detect And Control Future Epidemics

MaharashtraBombay HC on Potholes: Compensation for Deaths and Injuries to Be Deducted From Salaries of Civic Officials

MumbaiBombay HC Sets Up Expert Panel To Tackle Badlapur’s Chaotic Growth, Pushes For Planned Urban Development

MumbaiBombay High Court Receives Second Bomb Threat; Police Search Finds Nothing Suspicious

MumbaiBombay High Court Grants Interim Relief to Anil Ambani In Loan Fraud Case; Stops Bank Of Baroda From Taking Action

Maharashtra Realted Stories

MaharashtraNagpur Crime: 24-Year-Old Man Accused of Posting Ex-Girlfriend’s Nude Photos Online

MaharashtraKDMC Issues Notice to Kalyan Private School Over Ban on Religious Symbols

PunePune Crime: CCTV Footage Shows Two Men with Weapons Trying to Break Into Kothrud Society (VIDEO)

MumbaiMumbai Temple Theft: Jodhpur Man Arrested, 3 kg Silver Ornaments and Shivling Recovered

EntertainmentTanisha Mukerji Lights Up Mumbai Durga Puja with Graceful Dhunuchi Naach (Watch Video)